Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

Sharon J. Diskin, Mario Capasso, Robert W. Schnepp, Kristina A. Cole, Edward F. Attiyeh, Cuiping Hou, Maura Diamond, Erica L. Carpenter, Cynthia Winter, Hanna Lee, Jayanti Jagannathan, Valeria Latorre, Achille Iolascon, Hakon Hakonarson, Marcella Devoto, John M. Maris

Research output: Contribution to journalArticle

135 Citations (Scopus)

Abstract

Neuroblastoma is a cancer of the sympathetic nervous system that accounts for approximately 10% of all pediatric oncology deaths. Here, we report a genome-wide association study of 2,817 neuroblastoma cases and 7,473 controls. We identified two new associations at 6q16, the first within HACE1 (rs4336470; combined P = 2.7 × 10 -11; odds ratio 1.26, 95% confidence interval (CI) 1.18-1.35) and the second within LIN28B (rs17065417; combined P = 1.2 × 10 -8; odds ratio 1.38, 95% CI 1.23-1.54). Expression of LIN28B and let-7 miRNA correlated with rs17065417 genotype in neuroblastoma cell lines, and we observed significant growth inhibition upon depletion of LIN28B, specifically in neuroblastoma cells that were homozygous for the risk allele. Low HACE1 and high LIN28B expression in diagnostic primary neuroblastomas were associated with worse overall survival (P = 0.008 and 0.014, respectively). Taken together, these data show that common variants in HACE1 and LIN28B influence neuroblastoma susceptibility and indicate that both genes likely have a role in disease progression.

Original languageEnglish
Pages (from-to)1126-1130
Number of pages5
JournalNature Genetics
Volume44
Issue number10
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Neuroblastoma
Odds Ratio
Confidence Intervals
Genome-Wide Association Study
Sympathetic Nervous System
MicroRNAs
Disease Progression
Alleles
Genotype
Pediatrics
Cell Line
Growth
Genes
Neoplasms

ASJC Scopus subject areas

  • Genetics

Cite this

Diskin, S. J., Capasso, M., Schnepp, R. W., Cole, K. A., Attiyeh, E. F., Hou, C., ... Maris, J. M. (2012). Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nature Genetics, 44(10), 1126-1130. https://doi.org/10.1038/ng.2387

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. / Diskin, Sharon J.; Capasso, Mario; Schnepp, Robert W.; Cole, Kristina A.; Attiyeh, Edward F.; Hou, Cuiping; Diamond, Maura; Carpenter, Erica L.; Winter, Cynthia; Lee, Hanna; Jagannathan, Jayanti; Latorre, Valeria; Iolascon, Achille; Hakonarson, Hakon; Devoto, Marcella; Maris, John M.

In: Nature Genetics, Vol. 44, No. 10, 10.2012, p. 1126-1130.

Research output: Contribution to journalArticle

Diskin, SJ, Capasso, M, Schnepp, RW, Cole, KA, Attiyeh, EF, Hou, C, Diamond, M, Carpenter, EL, Winter, C, Lee, H, Jagannathan, J, Latorre, V, Iolascon, A, Hakonarson, H, Devoto, M & Maris, JM 2012, 'Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma', Nature Genetics, vol. 44, no. 10, pp. 1126-1130. https://doi.org/10.1038/ng.2387
Diskin, Sharon J. ; Capasso, Mario ; Schnepp, Robert W. ; Cole, Kristina A. ; Attiyeh, Edward F. ; Hou, Cuiping ; Diamond, Maura ; Carpenter, Erica L. ; Winter, Cynthia ; Lee, Hanna ; Jagannathan, Jayanti ; Latorre, Valeria ; Iolascon, Achille ; Hakonarson, Hakon ; Devoto, Marcella ; Maris, John M. / Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. In: Nature Genetics. 2012 ; Vol. 44, No. 10. pp. 1126-1130.
@article{b76ce6057813466cb68b1ead555d3d85,
title = "Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma",
abstract = "Neuroblastoma is a cancer of the sympathetic nervous system that accounts for approximately 10{\%} of all pediatric oncology deaths. Here, we report a genome-wide association study of 2,817 neuroblastoma cases and 7,473 controls. We identified two new associations at 6q16, the first within HACE1 (rs4336470; combined P = 2.7 × 10 -11; odds ratio 1.26, 95{\%} confidence interval (CI) 1.18-1.35) and the second within LIN28B (rs17065417; combined P = 1.2 × 10 -8; odds ratio 1.38, 95{\%} CI 1.23-1.54). Expression of LIN28B and let-7 miRNA correlated with rs17065417 genotype in neuroblastoma cell lines, and we observed significant growth inhibition upon depletion of LIN28B, specifically in neuroblastoma cells that were homozygous for the risk allele. Low HACE1 and high LIN28B expression in diagnostic primary neuroblastomas were associated with worse overall survival (P = 0.008 and 0.014, respectively). Taken together, these data show that common variants in HACE1 and LIN28B influence neuroblastoma susceptibility and indicate that both genes likely have a role in disease progression.",
author = "Diskin, {Sharon J.} and Mario Capasso and Schnepp, {Robert W.} and Cole, {Kristina A.} and Attiyeh, {Edward F.} and Cuiping Hou and Maura Diamond and Carpenter, {Erica L.} and Cynthia Winter and Hanna Lee and Jayanti Jagannathan and Valeria Latorre and Achille Iolascon and Hakon Hakonarson and Marcella Devoto and Maris, {John M.}",
year = "2012",
month = "10",
doi = "10.1038/ng.2387",
language = "English",
volume = "44",
pages = "1126--1130",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

AU - Diskin, Sharon J.

AU - Capasso, Mario

AU - Schnepp, Robert W.

AU - Cole, Kristina A.

AU - Attiyeh, Edward F.

AU - Hou, Cuiping

AU - Diamond, Maura

AU - Carpenter, Erica L.

AU - Winter, Cynthia

AU - Lee, Hanna

AU - Jagannathan, Jayanti

AU - Latorre, Valeria

AU - Iolascon, Achille

AU - Hakonarson, Hakon

AU - Devoto, Marcella

AU - Maris, John M.

PY - 2012/10

Y1 - 2012/10

N2 - Neuroblastoma is a cancer of the sympathetic nervous system that accounts for approximately 10% of all pediatric oncology deaths. Here, we report a genome-wide association study of 2,817 neuroblastoma cases and 7,473 controls. We identified two new associations at 6q16, the first within HACE1 (rs4336470; combined P = 2.7 × 10 -11; odds ratio 1.26, 95% confidence interval (CI) 1.18-1.35) and the second within LIN28B (rs17065417; combined P = 1.2 × 10 -8; odds ratio 1.38, 95% CI 1.23-1.54). Expression of LIN28B and let-7 miRNA correlated with rs17065417 genotype in neuroblastoma cell lines, and we observed significant growth inhibition upon depletion of LIN28B, specifically in neuroblastoma cells that were homozygous for the risk allele. Low HACE1 and high LIN28B expression in diagnostic primary neuroblastomas were associated with worse overall survival (P = 0.008 and 0.014, respectively). Taken together, these data show that common variants in HACE1 and LIN28B influence neuroblastoma susceptibility and indicate that both genes likely have a role in disease progression.

AB - Neuroblastoma is a cancer of the sympathetic nervous system that accounts for approximately 10% of all pediatric oncology deaths. Here, we report a genome-wide association study of 2,817 neuroblastoma cases and 7,473 controls. We identified two new associations at 6q16, the first within HACE1 (rs4336470; combined P = 2.7 × 10 -11; odds ratio 1.26, 95% confidence interval (CI) 1.18-1.35) and the second within LIN28B (rs17065417; combined P = 1.2 × 10 -8; odds ratio 1.38, 95% CI 1.23-1.54). Expression of LIN28B and let-7 miRNA correlated with rs17065417 genotype in neuroblastoma cell lines, and we observed significant growth inhibition upon depletion of LIN28B, specifically in neuroblastoma cells that were homozygous for the risk allele. Low HACE1 and high LIN28B expression in diagnostic primary neuroblastomas were associated with worse overall survival (P = 0.008 and 0.014, respectively). Taken together, these data show that common variants in HACE1 and LIN28B influence neuroblastoma susceptibility and indicate that both genes likely have a role in disease progression.

UR - http://www.scopus.com/inward/record.url?scp=84866887187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866887187&partnerID=8YFLogxK

U2 - 10.1038/ng.2387

DO - 10.1038/ng.2387

M3 - Article

VL - 44

SP - 1126

EP - 1130

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 10

ER -